BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11315357)

  • 1. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy.
    Petri M
    Lupus; 2001; 10(3):222-6. PubMed ID: 11315357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estrogen use in systemic lupus erythematosus].
    Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
    Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of exogenous estrogens in systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    Semin Arthritis Rheum; 2001 Jun; 30(6):426-35. PubMed ID: 11404826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of estrogen in women with systemic lupus erythematosus--should, should not?].
    Ostensen M
    Tidsskr Nor Laegeforen; 1996 Nov; 116(27):3237-9. PubMed ID: 9011978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.
    Rojas-Villarraga A; Torres-Gonzalez JV; Ruiz-Sternberg ÁM
    PLoS One; 2014; 9(8):e104303. PubMed ID: 25137236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal therapy in systemic lupus erythematosus].
    Kaliterna DM; Krstulović DM; Radić M
    Reumatizam; 2009; 56(2):41-3. PubMed ID: 20429261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.
    Andreoli L; Bertsias GK; Agmon-Levin N; Brown S; Cervera R; Costedoat-Chalumeau N; Doria A; Fischer-Betz R; Forger F; Moraes-Fontes MF; Khamashta M; King J; Lojacono A; Marchiori F; Meroni PL; Mosca M; Motta M; Ostensen M; Pamfil C; Raio L; Schneider M; Svenungsson E; Tektonidou M; Yavuz S; Boumpas D; Tincani A
    Ann Rheum Dis; 2017 Mar; 76(3):476-485. PubMed ID: 27457513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement and contraceptive therapy in autoimmune diseases.
    Lateef A; Petri M
    J Autoimmun; 2012 May; 38(2-3):J170-6. PubMed ID: 22261500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus.
    Buyon JP
    J Am Med Womens Assoc (1972); 1998; 53(1):13-7. PubMed ID: 9458619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus.
    Holroyd CR; Edwards CJ
    Climacteric; 2009 Oct; 12(5):378-86. PubMed ID: 19591008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic lupus erythematosus (SLE): sexual hormones, contraception and pregnancy].
    Vanini G; Chizzolini C
    Rev Med Suisse; 2005 Apr; 1(15):991-4. PubMed ID: 15918278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen therapy in systemic lupus erythematosus.
    Askanase AD
    Treat Endocrinol; 2004; 3(1):19-26. PubMed ID: 15743110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapy in a patient with ovarian agenesis and possible SLE: a choice to be made.
    Idan R; Hajdu SD; Agmon-Levin N; Shoenfeld Y
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S43-5. PubMed ID: 20361224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive health in SLE.
    Askanase AD; Buyon JP
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):265-80. PubMed ID: 12041953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in systemic lupus erythematosus.
    Kreidstein S; Urowitz MB; Gladman DD; Gough J
    J Rheumatol; 1997 Nov; 24(11):2149-52. PubMed ID: 9375875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?
    Ramsey-Goldman R
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):72-3. PubMed ID: 16932632
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.